Which providers should communicate which critical information about a new medication? Patient, pharmacist, and physician perspectives.

Which providers should communicate which critical information about a new medication? Patient, pharmacist, and physician perspectives.

Item
http://www.wikidata.org/entity/Q37318113
Individualized Treatment of Neovascular Age-Related Macular Degeneration: What are Patients Gaining? Or Losing?An integrative review of drug utilization by the elderly in primary health careEnhancing communication about paediatric medicines: lessons from a qualitative study of parents' experiences of their child's suspected adverse drug reactionPatients' perspectives on nonadherence to statin therapy: a focus-group study.New prescriptions: how well do patients remember important information?Refining the Practice of Prescribing: Teaching Physician Learners How to Talk to Patients About a New Prescription.Factors associated with medication information in diabetes care: differences in perceptions between patients and health care professionals.Older patient, physician and pharmacist perspectives about community pharmacists' roles.Structural equation modeling of the proximal-distal continuum of adherence drivers.Adverse drug reactions: when the risk becomes a reality for patients.An efficacy trial of an electronic health record-based strategy to inform patients on safe medication use: The role of written and spoken communication.Attitudes toward disclosure of medication side effects: a nationwide survey of Korean patients, caregivers, and oncologists.Therapeutic efficacy of bevacizumab for age-related macular degeneration: what are the implications of CATT for routine management?Patient-perceived barriers and facilitators to the implementation of a medication review in primary care: a qualitative thematic analysis.Expectations, concerns, and needs of patients who start drugs for chronic conditions. A prospective observational study among community pharmacies in Serbia.How to meet patients' individual needs for drug information - a scoping review
P2860

Which providers should communicate which critical information about a new medication? Patient, pharmacist, and physician perspectives.

Item
http://www.wikidata.org/entity/Q37318113
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Which providers should communi ...... t, and physician perspectives.
@en
Which providers should communi ...... t, and physician perspectives.
@nl
type
label
Which providers should communi ...... t, and physician perspectives.
@en
Which providers should communi ...... t, and physician perspectives.
@nl
prefLabel
Which providers should communi ...... t, and physician perspectives.
@en
Which providers should communi ...... t, and physician perspectives.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Which providers should communi ...... t, and physician perspectives.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1532-5415.2008.02133.X
P407
P433
P478
P577
P5875
P698
P921
P932